Amit Vora, MD
Interventional Cardiology · New Haven, CTNPI 1023270410
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $311,578 of the $408,585 with a category attached, or 76.3%. Medtronic accounts for 92.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $119,972 and has fallen 79.4% since, to $24,773 in 2025. Among interventional cardiology clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 630 payments — averaging $648.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$379K
- Edwards Lifesciences$18K
- Abbott$4K
- E.r. Squibb & Sons, L.L.C.$3K
- Boston Scientific$2K
- Ancora Heart, Inc.$1K
- plus $1K from 5 others
Across 107 payments — averaging $1351.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Inari Medical, Inc.$95K
- Edwards Lifesciences$27K
- Medtronic$23K
What the payments were for
- Consulting fees$14,4884%
- Speaking & faculty fees$311,57876%
- Travel & lodging$66,51316%
- Food & beverage$16,0074%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 532 | $378,847 |
| Edwards Lifesciences | 38 | $18,391 |
| Abbott | 20 | $3,510 |
| E.r. Squibb & Sons, L.L.C. | 3 | $2,854 |
| Boston Scientific | 22 | $2,347 |
| Ancora Heart, Inc. | 7 | $1,251 |
| GE HealthCare | 2 | $1,150 |
| W. L. Gore & Associates, Inc. | 3 | $107 |
| Atricure, Inc. | 1 | $97 |
| Chiesi USA, Inc. | 1 | $18 |
| Corindus Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$262,283
- CoreValve Evolut$107,921
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$12,813
- Edwards SAPIEN 3 Transcatheter Heart Valve$2,075
- AccuCinch$1,190
- Watchman$1,161
- EVOQUE$451
- NAVITOR$297
- 3F$215
- GENERAL - STRUCTURAL HEART$186
- PORTICO$177
- Mitra Clip system$162
- GENERAL VASCULAR ACCESS$161
- MELODY TPV$148
- Micra$123
- GENERAL - STENTS$114
- GENERAL - THERAPIES$113
How this compares
$408,585 in reported general payments places this provider in the 95th percentile of 73 interventional cardiology providers in Connecticut.
See all interventional cardiology providers in Connecticut →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in New Haven
- Michael NannaNew Haven$60K
- Sameer NagpalNew Haven$43K
- Michael ChrissoherisNew Haven$24K
- Hari DeshpandeNew Haven$23K
- Samit ShahNew Haven$19K
- Yasin HussainNew Haven$13K
- Brad StairNew Haven$7K
- Chirag ShahNew Haven$5K
- Scott WillisNew Haven$4K
- Rabih TabetNew Haven$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.